ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 118 filers reported holding ANIKA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $206,853 | -13.5% | 7,962 | -4.4% | 0.00% | 0.0% |
| Q1 2023 | $239,238 | -55.2% | 8,330 | -53.8% | 0.00% | -25.0% |
| Q4 2022 | $533,984 | +93.5% | 18,040 | +55.5% | 0.00% | 0.0% |
| Q3 2022 | $276,000 | +5.3% | 11,605 | -1.1% | 0.00% | +33.3% |
| Q2 2022 | $262,000 | -19.1% | 11,734 | -9.0% | 0.00% | -25.0% |
| Q1 2022 | $324,000 | -27.4% | 12,899 | +3.6% | 0.00% | -20.0% |
| Q4 2021 | $446,000 | – | 12,449 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Trigran Investments, Inc. | 1,154,183 | $25,761,000 | 3.00% |
| CAPITAL MANAGEMENT CORP /VA | 275,130 | $6,141,000 | 1.52% |
| Kent Lake Capital LLC | 98,570 | $2,200,000 | 1.21% |
| DIKER MANAGEMENT LLC | 21,835 | $487,000 | 0.60% |
| Portolan Capital Management | 235,972 | $5,267,000 | 0.53% |
| Riverwater Partners LLC | 12,466 | $278,000 | 0.28% |
| Ranger Investment Management | 139,661 | $3,117,000 | 0.24% |
| Invenomic Capital Management LP | 144,287 | $3,220,000 | 0.23% |
| CHATHAM CAPITAL GROUP, INC. | 23,787 | $531,000 | 0.12% |
| Teton Advisors, Inc. | 22,000 | $491,000 | 0.10% |